Mural Oncology PLC MURA
$2.03 $0.01 (0.49%) 1D
Last Updated: Dec 04, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Mural Oncology PLC Stock Halal?
Shariah Compliance Analysis of MURA Stock
Germany Health Care Nano Cap No. As of September 2026, Mural Oncology PLC (MURA) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Mural Oncology PLC does not pass Musaffa's business and financial screening criteria.
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. The company is headquartered in Dublin, Dublin and currently employs 116 full-time employees. The company went IPO on 2023-11-03. The firm is a biotechnology company focused on using its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer with the goal of delivering meaningful and clinical benefits to people living with cancer. The firm is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. The lead product candidate, nemvaleukin alfa (nemvaleukin), is an investigational-engineered cytokine fusion protein that selectively binds to the intermediate-affinity interleukin-2 (IL-2) receptor. The firm has also developed engineered therapies targeting the interleukin-18 (IL-18) and interleukin-12 (IL-12) pathways, which have demonstrated therapeutic potential in third-party preclinical and clinical studies.
MURA Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Mural Oncology PLC is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Mural Oncology PLC (MURA) Chart
Financial Metrics & Statements of Mural Oncology PLC (MURA)
FAQ's for Mural Oncology PLC (MURA)
- As of September 2026, Mural Oncology PLC MURA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mural Oncology PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Mural Oncology PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Mural Oncology PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Mural Oncology PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Mural Oncology PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Mural Oncology PLC (MURA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
